Alamar Biosciences Stock Forecast
NASDAQ: ALMRHealthcareMedical DevicesUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 27.77 0.00%
ALMR analyst consensus
Consensus (5 analysts)
buy
Avg. price target
$35.40+27.48%
- Strong buy 1
- Buy 3
- Hold 1
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 5 Wall Street analysts covering Alamar Biosciences (2026-10-07), 4 rate the stock a buy or strong buy, 1 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "buy". The average 12-month price target is $35.40, with a high estimate of $45.00 and a low estimate of $31.00. The average target implies upside of 27.5% from the current price of $27.77.
The spread between the highest and lowest targets is 45.2%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for ALMR.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 1 | 20% |
| Buy | 3 | 60% |
| Hold | 1 | 20% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-07.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $31.00 | +11.63% |
| Average target | $35.40 | +27.48% |
| High target | $45.00 | +62.05% |